About Capra Biosciences
Capra Biosciences is a private company based in Manassas, Virginia, incorporated in 2020 in Delaware. It has reported $3,950,000 raised in three offerings on Form D since January 2022. Its chief executive is Elizabeth Onderko.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 16, 2024 | Oct 1, 2024 | $500,000of $1.5M target | 1 | $500K | Equity, Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Nov 28, 2023 | Dec 12, 2023 | $3,400,000of $5.0M target | 9 | $377K | EquityRule 506(b) | Form D ↗ |
| Dec 20, 2021 | Jan 4, 2022 | $50,000of $1.5M target | 1 | $50,000 | SAFERule 506(b) | Form D ↗ |
| Total, three offerings | $3,950,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Capra Biosciences's Form D filed Oct 1, 2024.
AM
Andrew Magyar
Executive officer and director
EO
Elizabeth Onderko
Chief Executive Officer and director
PW
Pae Wu
Director
DC
Douglas Cameron
Director
DJ
Danielle Joseph
Director